No abstract available
MeSH terms
-
Adenoma / microbiology
-
Animals
-
Anti-Bacterial Agents / pharmacology
-
Anti-Inflammatory Agents / metabolism
-
Anti-Inflammatory Agents / pharmacology
-
Bacterial Toxins / genetics
-
Bacterial Toxins / isolation & purification
-
Bacteroides fragilis / drug effects
-
Bacteroides fragilis / isolation & purification
-
Bacteroides fragilis / pathogenicity
-
Bacteroides fragilis / physiology
-
Butyrates / metabolism
-
Butyrates / pharmacology
-
Case-Control Studies
-
Cell Proliferation / drug effects
-
Colorectal Neoplasms / etiology*
-
Colorectal Neoplasms / genetics
-
Colorectal Neoplasms / microbiology*
-
Colorectal Neoplasms / pathology
-
Diet / adverse effects
-
Disease Models, Animal
-
Escherichia coli / drug effects
-
Escherichia coli / isolation & purification
-
Escherichia coli / pathogenicity
-
Escherichia coli / physiology
-
Fusobacterium / drug effects
-
Fusobacterium / isolation & purification
-
Fusobacterium / physiology
-
Germ-Free Life
-
Healthy Volunteers
-
Humans
-
Inflammatory Bowel Diseases / microbiology
-
Inflammatory Bowel Diseases / pathology
-
Interleukin-17 / adverse effects
-
Interleukin-17 / immunology
-
Metagenome / genetics
-
Metagenome / physiology
-
Metalloendopeptidases / genetics
-
Metalloendopeptidases / isolation & purification
-
Mice
-
Microbiota / genetics
-
Microbiota / physiology*
-
Mutagens / pharmacology
-
Probiotics / pharmacology
-
Probiotics / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents
-
Bacterial Toxins
-
Butyrates
-
Interleukin-17
-
Mutagens
-
Bacteroides fragilis toxin
-
Metalloendopeptidases